[
  {
    "ts": null,
    "headline": "S&P 500 Gains and Losses Today: Chip Stocks Surge as Holiday Trading Week Begins",
    "summary": "The S&P 500 added 0.7% on Monday, Dec. 23, 2024, with tech stocks outperforming as the holiday-shortened week got underway.",
    "url": "https://finnhub.io/api/news?id=71c65c1a05ee9e6dc73719d40886e93eed5aa770944d1784e184a3ec2e3e21ad",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1734990166,
      "headline": "S&P 500 Gains and Losses Today: Chip Stocks Surge as Holiday Trading Week Begins",
      "id": 132124021,
      "image": "https://www.investopedia.com/thmb/6zY9Nw1Vxkrtr0LZqTOlpxEtPy4=/1500x0/filters:no_upscale():max_bytes(150000):strip_icc()/GettyImages-2189656773-518305a72e6c40d18af8a92063a5319b.jpg",
      "related": "RMD",
      "source": "Yahoo",
      "summary": "The S&P 500 added 0.7% on Monday, Dec. 23, 2024, with tech stocks outperforming as the holiday-shortened week got underway.",
      "url": "https://finnhub.io/api/news?id=71c65c1a05ee9e6dc73719d40886e93eed5aa770944d1784e184a3ec2e3e21ad"
    }
  },
  {
    "ts": null,
    "headline": "Sleep Apnea Device Maker Stocks Slide on FDA Ruling for Eli Lilly's Zepbound",
    "summary": "Shares of ResMed and Inspire Medical Systems fell after the FDA approved Eli Lilly's weight-loss drug Zepbound to treat moderate-to-severe obstructive sleep apnea in adults with obesity.",
    "url": "https://finnhub.io/api/news?id=f0f4e700791f08794dc8a84ae3835100769702ccaf743dfe32c970d4051fe499",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1734981907,
      "headline": "Sleep Apnea Device Maker Stocks Slide on FDA Ruling for Eli Lilly's Zepbound",
      "id": 132124053,
      "image": "https://www.investopedia.com/thmb/1Al6yUm6eeULcNDtRYzddJjl5cg=/1500x0/filters:no_upscale():max_bytes(150000):strip_icc()/GettyImages-2126120481-f80ae43f31204df79378fee13e344f48.jpg",
      "related": "RMD",
      "source": "Yahoo",
      "summary": "Shares of ResMed and Inspire Medical Systems fell after the FDA approved Eli Lilly's weight-loss drug Zepbound to treat moderate-to-severe obstructive sleep apnea in adults with obesity.",
      "url": "https://finnhub.io/api/news?id=f0f4e700791f08794dc8a84ae3835100769702ccaf743dfe32c970d4051fe499"
    }
  },
  {
    "ts": null,
    "headline": "Top Stock Movers Now: Broadcom, AMD, ResMed, and More",
    "summary": "Major U.S. indexes were mixed at midday Monday to start the holiday-shortened trading week.",
    "url": "https://finnhub.io/api/news?id=e2b6c68f054ba526d0316d2186af0324519d95ec65b5474d2c997b755a300aaa",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1734978838,
      "headline": "Top Stock Movers Now: Broadcom, AMD, ResMed, and More",
      "id": 132124027,
      "image": "https://www.investopedia.com/thmb/_e91aHwdjnw9qHn2JtwOeAfFwPE=/1500x0/filters:no_upscale():max_bytes(150000):strip_icc()/GettyImages-19806700676-4876f91af7c24127be77dcdb15c28120.jpg",
      "related": "RMD",
      "source": "Yahoo",
      "summary": "Major U.S. indexes were mixed at midday Monday to start the holiday-shortened trading week.",
      "url": "https://finnhub.io/api/news?id=e2b6c68f054ba526d0316d2186af0324519d95ec65b5474d2c997b755a300aaa"
    }
  },
  {
    "ts": null,
    "headline": "3 Reasons Growth Investors Will Love ResMed (RMD)",
    "summary": "ResMed (RMD) is well positioned to outperform the market, as it exhibits above-average growth in financials.",
    "url": "https://finnhub.io/api/news?id=96e54e1c902d25f7e3f368b6ecec2b8c2411d1e533bd1511a0739551888299b3",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1734975907,
      "headline": "3 Reasons Growth Investors Will Love ResMed (RMD)",
      "id": 132124055,
      "image": "https://media.zenfs.com/en/zacks.com/670d1917693293f70179651625deb88f",
      "related": "RMD",
      "source": "Yahoo",
      "summary": "ResMed (RMD) is well positioned to outperform the market, as it exhibits above-average growth in financials.",
      "url": "https://finnhub.io/api/news?id=96e54e1c902d25f7e3f368b6ecec2b8c2411d1e533bd1511a0739551888299b3"
    }
  },
  {
    "ts": null,
    "headline": "Why ResMed (RMD) is a Top Growth Stock for the Long-Term",
    "summary": "Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.",
    "url": "https://finnhub.io/api/news?id=67c4e4323359830176686212f63a93caac33990aa94c63173c0b85e889ed8dc0",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1734965112,
      "headline": "Why ResMed (RMD) is a Top Growth Stock for the Long-Term",
      "id": 132124056,
      "image": "https://media.zenfs.com/en/zacks.com/5ecaf2a9bf082a5f3a554e6526b34be0",
      "related": "RMD",
      "source": "Yahoo",
      "summary": "Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.",
      "url": "https://finnhub.io/api/news?id=67c4e4323359830176686212f63a93caac33990aa94c63173c0b85e889ed8dc0"
    }
  },
  {
    "ts": null,
    "headline": "Wall Street Lunch: Nordstrom To Go Private",
    "summary": "Department store chain Nordstrom (JWN) has accepted a $6.25 billion all-cash buyout offer to end its 53-year run as a publicly traded company.",
    "url": "https://finnhub.io/api/news?id=cda1d07dc4301357ff00adf0d7f794a87074699afbb53803ed3c773f0b75d715",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1734963420,
      "headline": "Wall Street Lunch: Nordstrom To Go Private",
      "id": 132122216,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1468727791/image_1468727791.jpg?io=getty-c-w1536",
      "related": "RMD",
      "source": "SeekingAlpha",
      "summary": "Department store chain Nordstrom (JWN) has accepted a $6.25 billion all-cash buyout offer to end its 53-year run as a publicly traded company.",
      "url": "https://finnhub.io/api/news?id=cda1d07dc4301357ff00adf0d7f794a87074699afbb53803ed3c773f0b75d715"
    }
  }
]